It also comes available as an extended-release form to provide longer-lasting pain relief
[1] Topiramate Topiramate is an oral antiepileptic drug (AED) used for partial-onset, generalized primary tonic-clonic seizures, and as an adjunct therapy in Lennox-Gastaut syndrome

Investigating mechanisms of appetite suppression and satiety via GLP1 and GIP pathways Studying energy expenditure and fat oxidation mediated by glucagon receptor activation Researching synergistic effects of triple-agonist peptides on body weight reduction Evaluating potential therapeutic strategies for severe obesity Examining insulin secretion, glucose homeostasis, and HbA1c improvement Researching effects on insulin sensitivity and pancreatic beta-cell function Studying incretin-based mechanisms in type 2 diabetes models Investigating lipid metabolism and cardiovascular markers Researching the impact of triple-receptor activation on overall metabolic profile Studying mechanisms underlying metabolic syndrome and related disorders Exploring multi-receptor agonist peptide design and structure-activity relationships Studying pharmacokinetics, receptor specificity, and chemical modifications to improve half-life and stability Evaluating preclinical safety, efficacy, and translational potential Retatrutide is used in research for obesity, metabolic disorders, type 2 diabetes, and cardiometabolic health , leveraging its triple-receptor mechanism (GLP1, GIP, glucagon) to study weight loss, glucose regulation, and metabolic improvements

FDA approvals for semaglutide: Ozempic (semaglutide) is FDA-approved to treat adults with type 2 diabetes
Beyond 12 weeks, continued use maintains effects rather than producing additional benefits
some guidance cites up to 12 months